Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Luba Hunakova"'
Autor:
Pavel Kotoucek, Robert Enright, Stanislava Gregor Sorgerova, Luba Hunakova, Veronika Chlebcova, Dana Cholujova, Jana Jakubikova, Boris Mravec, Eva Nanistova, Ludmila Panekova, Jan Sedlak
Publikováno v:
HemaSphere, Vol 7, p e8749633 (2023)
Externí odkaz:
https://doaj.org/article/5d1a0956fc8e428495162460822e1bfa
Autor:
Karolina Majerova, Milan Zvarik, Itay Ricon-Becker, Tsipi Hanalis-Miller, Iveta Mikolaskova, Vladimir Bella, Boris Mravec, Luba Hunakova
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Experimental and clinical studies have shown that the sympathetic nervous system (SNS) stimulates cancer progression and reduces the efficacy of oncological treatment. These effects may be reduced by pharmacological and psychotherapeutical a
Externí odkaz:
https://doaj.org/article/d71cedac20a44a44959ba7478769b7e4
Publikováno v:
Biology, Vol 12, Iss 2, p 158 (2023)
The correlation between pancreatic ductal adenocarcinoma (PDAC) and diabetes-related mechanisms support the hypothesis that early therapeutic strategies targeting diabetes can contribute to PDAC risk reduction and treatment improvement. A systematic
Externí odkaz:
https://doaj.org/article/b9924bbf365a419fbf6bbe2ab3a11038
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 21, p 7958 (2020)
The development and progression of cancer depends on both tumor micro- and macroenvironments. In addition, psychosocial and spiritual “environments” might also affect cancer. It has been found that the nervous system, via neural and humoral pathw
Externí odkaz:
https://doaj.org/article/adabb820d3ec48dca4d0ef5be45f5188
Publikováno v:
Medical Oncology. 39
Intensive investigation for novel antiproliferative and cytotoxic effective chemical compounds is currently concentrated on structurally modified agents of natural or synthetic source. The selenium derivative of triorganotin compound, triphenyltin is
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 5, p 1198 (2019)
The cytotoxicity of two recently synthesized triorganotin isothiocyanate derivatives, nuclear retinoid X receptor ligands, was tested and compared in estrogen-receptor-positive MCF 7 and -negative MDA-MB-231 human breast carcinoma cell lines. A 48 h
Externí odkaz:
https://doaj.org/article/9e1b5dc9c8184cd886084beb42163a06
Autor:
Danka Cholujova, Katarina Kozic, Miroslav Vlcek, Richard Imrich, Paulina Gronesova, Jan Sedlak, Luba Hunakova, Michaela Korbuly, Adela Penesova
Publikováno v:
General physiology and biophysics. 37:443-451
The aim of our prospective, interventional, pre-post, single arm study was to supplement the lack of knowledge of the effect of short-term Pilates intervention on selected blood parameters of healthy women. Female volunteers were recruited for 2-week
Publikováno v:
Anticancer research. 39(9)
Background/aim Triple-negative breast cancer (TNBC) constitutes 15-20% of all breast carcinomas, affecting younger women more often and has a worse prognosis than other types of breast cancer, due to the combination of more aggressive clinical behavi
Autor:
Vladimír Mastihuba, Peter Kis, Elena Karnišová Potocká, Mária Mastihubová, Eva Horváthová, Andrea Sevcovicova, Martina Klapakova, Eliška Gálová, Luba Hunakova
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 61
The study focused on protective potential of phytochemicals applicable in prevention and health protection is of great importance. Various structures of these compounds and a wide range of their biological activities have inspired organic chemists to
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 5
International Journal of Molecular Sciences, Vol 20, Iss 5, p 1198 (2019)
Volume 20
Issue 5
International Journal of Molecular Sciences, Vol 20, Iss 5, p 1198 (2019)
The cytotoxicity of two recently synthesized triorganotin isothiocyanate derivatives, nuclear retinoid X receptor ligands, was tested and compared in estrogen-receptor-positive MCF 7 and -negative MDA-MB-231 human breast carcinoma cell lines. A 48 h